[HTML][HTML] Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review

S Łukasiewicz, M Czeczelewski, A Forma, J Baj… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

An overview of PARP inhibitors for the treatment of breast cancer

L Cortesi, HS Rugo, C Jackisch - Targeted oncology, 2021 - Springer
Loss-of-function mutations in BRCA1 and BRCA2 are detected in at least 5% of unselected
patients with breast cancer (BC). These BC susceptibility genes encode proteins critical for …

Understanding breast cancer as a global health concern

L Wilkinson, T Gathani - The British journal of radiology, 2022 - academic.oup.com
Breast cancer is now the most commonly diagnosed cancer in the world. The most recent
global cancer burden figures estimate that there were 2.26 million incident breast cancer …

[HTML][HTML] US medical eligibility criteria for contraceptive use, 2024

AT Nguyen - MMWR. Recommendations and Reports, 2024 - cdc.gov
Summary The 2024 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by persons who …

Health and racial disparity in breast cancer

CG Yedjou, JN Sims, L Miele, F Noubissi… - … cancer metastasis and …, 2019 - Springer
Breast cancer is the most common noncutaneous malignancy and the second most lethal
form of cancer among women in the United States. It currently affects more than one in ten …

[HTML][HTML] Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

Y Feng, M Spezia, S Huang, C Yuan, Z Zeng, L Zhang… - Genes & diseases, 2018 - Elsevier
As the most commonly occurring cancer in women worldwide, breast cancer poses a
formidable public health challenge on a global scale. Breast cancer consists of a group of …

Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights

A Ragupathi, M Singh, AM Perez… - Frontiers in Cell and …, 2023 - frontiersin.org
BRCA1 and BRCA2 play a critical role in a variety of molecular processes related to DNA
metabolism, including homologous recombination and mediating the replication stress …

Cancer progress and priorities: breast cancer

SC Houghton, SE Hankinson - Cancer epidemiology, biomarkers & …, 2021 - aacrjournals.org
Breast cancer is the most commonly diagnosed invasive cancer among women both
globally and within the United States and the number one cause of cancer-related deaths …

Family history and risk of breast cancer: an analysis accounting for family structure

HR Brewer, ME Jones, MJ Schoemaker… - Breast cancer research …, 2017 - Springer
Purpose Family history is an important risk factor for breast cancer incidence, but the
parameters conventionally used to categorize it are based solely on numbers and/or ages of …

[HTML][HTML] US medical eligibility criteria for contraceptive use, 2016

KM Curtis - MMWR. Recommendations and Reports, 2016 - cdc.gov
Summary The 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by women and …